Georgia Department of Economic Development’s EJane Caraway and Georgia Research Alliance’s Susan Shows to be Honored

ATLANTA, GA (March 3, 2021) – Georgia Bio, the state’s life science trade association, will virtually celebrate its annual Golden Helix Awards on Thursday, April 1st. Georgia Bio is pleased to announce the winners of the 2021 Golden Helix Awards. 

Share this on Twitter
Georgia Bio is pleased to announce the winners of the 2021 Golden Helix Awards. Georgia Department of Economic Development’s EJane Caraway and Georgia Research Alliance’s Susan Shows to receive top award, the Industry Growth Award. #GaBioAwards #Awards @ga_res_alliance @gdecd

EJane Caraway , Director of Life Sciences for the Georgia Department of Economic Development (GDEcD) and Susan Shows , President of the Georgia Research Alliance (GRA) are the recipients of the 2021 Industry Growth Awards for their impact on the life sciences industry in the state. The Industry Growth Awards are the highest honors bestowed each year by Georgia Bio. 

The Golden Helix Awards celebrate the contributions and achievements of Georgia legislative, academic, corporate and other organizational leaders working to advance the growth of the life sciences industry and foster strategic partnerships that can create a healthier world. The event is expected to draw 300 of the state’s life sciences industry leaders. 

“This past year has truly put a spotlight on the importance of the life sciences industry in our everyday lives,” said David Hartnett, Chief Economic Development Officer at the Metro Atlanta Chamber and member of the Georgia Bio Awards Committee. “The coronavirus pandemic created an immediate need for our community to collaborate and foster innovation to combat COVID. Our leaders did not disappoint, and we look forward to celebrating their efforts on April 1 st .” 

Now in its 23 rd year, the Golden Helix Award winners showcase the best in innovation and leadership in Georgia’s community. Georgia Bio presents awards to individuals and companies in nine categories: Industry Growth; Lifetime Achievement; Deals of the Year; Community; Innovation; Emerging Leader; Biotech Teacher of the Year; Legislator of the Year; and the Metro Atlanta Chamber sponsored Phoenix Award. Winners are some of Georgia’s hardest working innovators and entrepreneurs producing advanced medicines, diagnostics and technologies to improve medical care. 

Companies being honored with the distinguished Deal of the Year award include: Children’s Healthcare of Atlanta, the Emory University and the Georgia Institute of Technology for receiving $18.2 million to continue their verification of COVID-19 diagnostic tests; CryoLife for its acquisition of Florida-based Ascyrus Medical for up to $200 million; Georgia Cancer Center for receiving a $3.3 million grant to cut cancer cases and deaths in underserved Georgians; Medline Industries economic development in Richmond Hill of a $70 million new distribution center creating 150 new jobs; RWDC Industries economic development in Athens of a $260 million factory and headquarters employing 200 people; and VERO Biotech for its $50 million funding agreement with Runway Capital.

“Though much has been lost to COVID-19, our nation – Georgia especially – has gained a deeper appreciation of the value that our industry provides. I look forward to taking an evening to recognize the individuals and companies who are working to combat this devastating disease with new devices, drugs, and therapeutics,” said Maria Thacker Goethe, President and CEO, Georgia Bio, “Our community strives to improve patients’ lives, support workforce development and grow Georgia’s economy, and our celebration will highlight those lasting contributions made by many in the life sciences sector in Georgia.”

AWARD WINNERS 

Georgia Bio Industry Growth Awards : Presented to two people who have made an extraordinary contribution to the growth of the life sciences industry in Georgia.

  • EJane Caraway, Director of Life Sciences, Georgia Department of Economic Development
  • Susan Shows, President, Georgia Research Alliance

Georgia Bio Lifetime Achievement Award : Presented to an individual who has dedicated their career to advancing innovation, entrepreneurship, and economic development in the life sciences industry of Georgia.

  • Dr. David Lee, Vice President for Research, University of Georgia

Phoenix Award : Presented to two Georgia honorees who have fostered innovation and collaboration within the community in Georgia and beyond in response to the coronavirus pandemic. This award is sponsored by the Metro Atlanta Chamber. 

  • U.S. Centers for Disease Control and Prevention
  • Global Health Crisis Coordination Center, a division of the Center for Global Health Innovation

Deals of the Year Awards : Presented to one or more companies or institutions for the most significant financial or commercial transactions closed from November 1, 2019-December 31, 2020, based on the importance of the transaction to Georgia’s life sciences industry. 

Acquisitions 

CryoLife’s Acquisition of Ascyrus Medical

Economic Development

Medline Industries

RWDC Industries

Private Financing 

VERO Biotech

Public Financing 

Georgia Cancer Center

Children’s Healthcare of Atlanta | Emory University | Georgia Institute of Technology

Community Awards : Presented to a small number of individuals, companies or institutions whose contributions to Georgia’s life sciences community are worthy of special recognition. 

  • Carl Clark, Augusta University
  • Nancy Paris, Georgia CORE
  • James Rains, Jackson Medical & Georgia Institute of Technology
  • Shaker Reddy, Metaclipse Therapeutics

Innovation Awards : Presented to the department, institution, company or individuals who are forging new ground by thinking outside traditional paradigms to create some unique technology. 

  • 3D printed COVID-19 testing nasal swabs, Dental College of Georgia
  • PPE Face Shields, Saldana Research Group | Global Center for Medical Innovation | Georgia Institute of Technology
  • Blockchain in Patient Trials, Patientory, Inc.

Emerging Leader of the Year Awards : Presented to young individuals who have made a significant impact on the life sciences industry through their studies or employment. 

  • Brian Jurgielewicz, University of Georgia
  • Tarianna Stewart, Ph.D., IBM

Teacher of the Year Award : Presented to a Georgia biotechnology high school teacher who exhibits excellence in STEM teaching and support for the biotechnology pathway. 

  • Dr. Brittney Denier Cantrell, Denmark High School

Legislators of the Year Award : Presented to state legislators for their support of the life sciences industry in Georgia. 

  • The Honorable Dean Burke, MD, Georgia State Senate
  • The Honorable David Knight, Georgia House of Representatives

For a list of past Georgia Bio Industry Growth Award recipients, click here. 

ABOUT GEORGIA BIO (GaBio) 

Georgia Bio (GaBio) is the state’s life science advocacy and business leadership industry association whose members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services. GaBio works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow Georgia’s life sciences economy. Visit GaBio at www.gabio.org , and follow us on Twitter @Georgia_Bio , Facebook , and LinkedIn. 

Georgia Bio is a division of the Center for Global Health Innovation (CGHI), a 501(c)(3) organization that was launched in January 2020 to bring together diverse Global Health, Health Technology and Life Sciences entities to collaborate, innovate and activate solutions to enhance human health outcomes around the world. Visit CGHI at www.innovateglobalhealth.org. 

Credentialed members of the news media are invited to attend as guests. Please register with Georgia Bio. 

Media Contact:

Kristina Forbes 

404-920-2043 

kforbes@gabio.org

Georgia Life Sciences Designates City of Atlanta as Newest BioReady® Community

By Sheran Brown • February 21, 2025
Georgia Life Sciences Designates City of Atlanta as Newest BioReady® Community

Bipartisan PBM Reform Back in Focus as House Committee Plans Hearing

By Sheran Brown • February 20, 2025
A renewed push for prescription drug cost reform is gaining momentum in Congress, with the House Energy and Commerce Committee's health subcommittee planning a hearing on pharmacy benefit manager (PBM) reform for late February. The hearing, to be led by Rep. Buddy Carter (R-Ga.), signals a revival of bipartisan efforts to regulate these pharmaceutical intermediaries. PBMs, which negotiate drug prices for insurers and employers, have become a focal point in the broader discussion of healthcare costs. A previous bipartisan agreement to regulate these entities was crafted by Carter and Rep. Diana DeGette (D-Colo.) in the last Congress, though it ultimately stalled when the larger spending bill it was attached to faced opposition. The reform efforts enjoy broad support from both parties and the president, making it one of the few areas with potential for bipartisan cooperation. However, new complications have emerged as Republicans consider using PBM regulations to generate savings for their broader policy agenda, potentially requiring up to $880 billion in cost reductions. The path forward remains uncertain, with ongoing debates about whether such reforms would qualify for budget reconciliation and whether using PBM regulations as a funding mechanism could derail bipartisan cooperation. Meanwhile, stakeholders continue to disagree on the impact of additional PBM regulation, with pharmaceutical companies arguing that PBMs inflate drug costs while PBMs contend that new regulations would increase prices.

Council on State Biotechnology Associations says NIH funds are a critical component of innovation ecosystem

By Sheran Brown • February 20, 2025
The Council of State Biotechnology Associations (CSBA) has issued a strong warning about proposed cuts to National Institutes of Health (NIH) funding, emphasizing the critical role these grants play in America's biotech innovation ecosystem. The statement, below , comes amid concerns over recent guidance that would reduce NIH funding to key research institutions. ----------------------- “Today, the US biotech industry employs nearly 2.3 million people across the US and is making positive contributions to economic impact and national security across all 50 states. In fact, for every dollar the National Institutes of Health (NIH) contributes to a successful drug, the private sector invests over $65, underscoring the agency’s unparalleled return on investment. As the associations representing the bioscience industry across the nation, the Council on State Biotechnology Associations (CSBA) is concerned by recent guidance that would cut funding provided by the NIH to universities, hospitals, and other institutions that perform critical early-stage research. NIH grant funds are a critical component of our innovation ecosystem. Grants for basic research are the spark that leads to university-driven discoveries, with public-private partnerships and tech transfers that bridge early-stage research to industry-sponsored drug development and ultimately to FDA approved medical advances for hundreds of diseases. While the administration looks for greater efficiency in the use of taxpayer dollars, it cannot be overstated - once scientific innovation moves abroad, it may never return. In the race for scientific innovation around the world, as our adversaries continue to increase government investments in research, we encourage President Trump to follow suit and ensure that we maintain our global leadership in an industry that was created and thrives across the US.”
MORE POSTS
Share by: